XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 62.02%1.15B | 52.85%460.33M | 214.57%419.77M | 59.87%144.19M | -30.85%129.58M | 218.31%712.18M | 282.38%301.17M | 183.52%133.44M | 44.47%90.19M | 428.16%187.38M |
Net income from continuing operations | 115.26%467.92M | -20.61%76.94M | 103.35%149.34M | 386.40%135.57M | 453.87%106.07M | 158.58%217.38M | 189.39%96.91M | 159.28%73.44M | 115.54%27.87M | 118.89%19.15M |
Depreciation and amortization | -5.30%31.59M | -12.12%7.01M | -6.65%8.09M | -4.08%8.06M | 1.42%8.44M | 48.10%33.35M | 8.12%7.97M | 45.79%8.66M | 71.58%8.4M | 92.95%8.32M |
Deferred tax | ---- | ---- | ---- | ---- | ---- | -2,662.07%-4.81M | ---- | ---- | ---- | ---- |
Other non cash items | 146.53%13.51M | 81.79%-2.85M | 1,567.55%31.5M | 25.45%-8.82M | -84.11%-6.32M | -805.77%-29.04M | 54.41%-15.67M | -88.29%1.89M | -254.93%-11.83M | -146.43%-3.43M |
Change In working capital | -1,224.07%-70.1M | 25.79%104.16M | 225.56%82.44M | -174.54%-140.07M | -390.73%-116.62M | 102.39%6.24M | 221.16%82.8M | -29.19%-65.66M | 7.30%-51.02M | 146.10%40.11M |
-Change in receivables | -98.91%-211.16M | 87.60%100.54M | 70.95%-13.39M | -51.61%-176.43M | -4,599.22%-121.88M | -45.78%-106.16M | -34.46%53.59M | 41.55%-46.09M | -1,078.81%-116.37M | 104.11%2.71M |
-Change in prepaid assets | 216.22%7.2M | 536.93%26.75M | -1,338.51%-16.77M | -13,672.05%-22.17M | 1,449.44%19.4M | 75.02%-6.2M | 69.86%-6.12M | -103.85%-1.17M | 99.47%-161K | 128.98%1.25M |
-Change in payables and accrued expense | 359.54%96.79M | -7.79%46.93M | 693.13%27.04M | 74.68%18.12M | 113.19%4.7M | 186.57%21.06M | 710.36%50.9M | 81.66%-4.56M | -83.16%10.37M | 32.40%-35.65M |
-Change in other current assets | 44.39%4.68M | -51.96%625K | -127.92%-1.52M | 91.93%2.05M | 177.46%3.53M | -46.26%3.24M | 129.19%1.3M | 125.80%5.43M | -79.48%1.07M | -257.42%-4.55M |
-Change in other current liabilities | 10.41%-44.41M | -26.37%-15.15M | 0.06%-11.99M | 88.34%-1.76M | -47.54%-15.52M | -43.01%-49.57M | -70.52%-11.99M | -17.77%-12M | -115.84%-15.07M | -0.51%-10.52M |
-Change in other working capital | -46.62%76.8M | -1,038.90%-55.54M | 1,461.61%99.07M | -41.98%40.12M | -107.88%-6.85M | 230.04%143.86M | 95.57%-4.88M | -123.98%-7.28M | 192.83%69.14M | 99.76%86.87M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 62.02%1.15B | 52.85%460.33M | 214.57%419.77M | 59.87%144.19M | -30.85%129.58M | 218.31%712.18M | 282.38%301.17M | 183.52%133.44M | 44.47%90.19M | 428.16%187.38M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 87.44%-340.66M | 212.47%640.19M | -63.42%-320.73M | 61.93%-148.88M | 67.11%-511.25M | -5,868.21%-2.71B | -878.90%-569.23M | -617.76%-196.26M | -7,473.66%-391.1M | -1,511.51%-1.55B |
Net PPE purchase and sale | 16.41%-12.63M | 36.09%-3.11M | -154.63%-3.99M | 26.82%-2.88M | 43.97%-2.66M | 62.24%-15.11M | 1.18%-4.86M | 89.16%-1.57M | 27.92%-3.93M | 68.75%-4.76M |
Net business purchase and sale | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Net investment purchase and sale | 88.04%-322.41M | 214.27%644.92M | -62.68%-316.74M | 63.32%-142M | 67.18%-508.58M | -3,635.15%-2.7B | -5,130.90%-564.37M | -1,408.36%-194.7M | -3,697.52%-387.17M | -1,807.42%-1.55B |
Net other investing changes | ---5.62M | ---1.62M | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 87.44%-340.66M | 212.47%640.19M | -63.42%-320.73M | 61.93%-148.88M | 67.11%-511.25M | -5,868.21%-2.71B | -878.90%-569.23M | -617.76%-196.26M | -7,473.66%-391.1M | -1,511.51%-1.55B |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 111.74%463.36M | 365.85%238.66M | 197.27%151.43M | -102.18%-1.98M | 189.60%75.25M | 154.48%218.84M | 261.88%51.23M | 112.33%50.94M | 340.06%90.68M | -4.62%25.98M |
Net issuance payments of debt | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Net common stock issuance | ---64.2M | ---18.6M | ---18.9M | ---17.7M | ---9M | ---- | ---- | --0 | --0 | --0 |
Proceeds from stock option exercised by employees | 241.55%745.4M | 824.33%475.19M | 236.93%170.34M | -82.26%16.03M | 223.41%83.84M | 153.50%218.24M | 267.71%51.41M | 105.79%50.56M | 344.72%90.35M | -4.78%25.92M |
Net other financing activities | -36,345.59%-217.84M | -123,022.60%-217.93M | -102.86%-11K | -191.34%-306K | 591.53%408K | 746.24%601K | -200.57%-177K | 166.67%384K | 15.12%335K | 268.75%59K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 111.74%463.36M | 365.85%238.66M | 197.27%151.43M | -102.18%-1.98M | 189.60%75.25M | 154.48%218.84M | 261.88%51.23M | 112.33%50.94M | 340.06%90.68M | -4.62%25.98M |
Net cash flow | ||||||||||
Beginning cash position | -67.64%850.11M | -25.75%788.46M | -50.46%532.08M | -58.13%539.67M | -67.64%850.11M | 11.00%2.63B | -56.71%1.06B | -55.53%1.07B | -44.75%1.29B | 11.00%2.63B |
Current changes in cash | 171.71%1.28B | 717.64%1.34B | 2,208.18%250.47M | 96.83%-6.67M | 77.15%-306.42M | -773.52%-1.78B | -230.61%-216.82M | -127.18%-11.88M | -337.96%-210.22M | -3,874.02%-1.34B |
Effect of exchange rate changes | -330.20%-6.75M | -252.79%-7.71M | 2,389.92%5.91M | 79.61%-924K | -250.37%-4.02M | 175.42%2.93M | -41.26%5.04M | 95.79%-258K | 19.29%-4.53M | 468.09%2.68M |
End cash Position | 149.37%2.12B | 149.37%2.12B | -25.75%788.46M | -50.46%532.08M | -58.13%539.67M | -67.64%850.11M | -67.64%850.11M | -56.71%1.06B | -55.53%1.07B | -44.75%1.29B |
Free cash flow | 63.72%1.14B | 54.30%457.22M | 215.28%415.79M | 63.82%141.31M | -30.50%126.92M | 279.44%697.07M | 301.26%296.31M | 304.16%131.88M | 51.40%86.26M | 801.30%182.62M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |